Recommended Articles Abstract Objective: To determine whether broad-spectrum antibiotic therapy administered after a failed in Invitro prosztatitis fertilization IVF cycle will improve the chance of achieving a successful pregnancy in the subsequent IVF cycle and to determine whether further antibiotic therapy administered immediately after conception, during the course of pregnancy, and at the time of delivery will reduce the incidence of maternal and fetal complications.
Design: A retrospective analysis was performed on the clinical data of 63 couples who had previously failed one or more IVF cycles and were subsequently treated with broad-spectrum antibiotics.
Invitro prosztatitis women were treated with intravenous Clindamycin and Invitro prosztatitis intrauterine lavages using a broad-spectrum Invitro prosztatitis combination. All men received intravenous Clindamycin and simultaneously underwent five direct transrectal injections of an antibiotic cocktail into the prostate gland if clinical or sonographic evidence of chronic prostatitis was documented.
For both men and women, these regimens were followed by a month-long oral course of Zithromax and Macrobid.
Following either a spontaneous pregnancy or a repeat IVF conception, a day antibiotic course was administered in the form of oral Cleocine or intravenous Clindamycin. Some women received intermittent oral antibiotic courses throughout the pregnancy and prophylactic antibiotics during delivery.
Results: When compared with our previous study Study I, the number of spontaneous pregnancies was significantly higher and the total number of births was also significantly higher. Following the antibiotic therapy, there was a significantly improved chance for the couples to achieve a successful IVF pregnancy when compared to historical Invitro prosztatitis in conventional repeat IVF cycles. For singleton pregnancies, there were no perinatal maternal or fetal complications.
Conclusion: These results support our previous findings, showing that antibiotic therapy can reduce IVF failures in subsequent cycles. The reduced number of maternal and fetal complications after antibiotic therapy in this retrospective study is impressive and warrants a prospective, randomized trial for confirmation.